Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Baricitinib is effective for severe alopecia areata but has some side effects.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Oleanolic acid improved hair growth in mice by affecting hair growth pathways and reducing inflammation.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Blocking LFA-1 prevents hair loss in mice.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Two new compounds were found to effectively reduce hair growth in mice.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Vitamin A affects hair loss and immune response in alopecia areata.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

KeraGLO improves skin and hair health.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.